Brielle Benyon

From odor to diet concerns, a nurse practitioner answers common questions about colostomies and ileostomies from patients with cancer.

The FDA approved Elahere for patients with pretreated, folate receptor alpha (FRα)-positive platinum-resistant gynecological cancers

Patients with myelofibrosis should be open about their treatment goals with their providers, and potentially consider getting a second opinion or participating in a clinical trial, one expert says.

After being diagnosed with sarcoma while deployed overseas, military veteran Brandi Benson realized the importance of speaking up about health complications.

From the singer of “Duran Duran” revealing his stage 4 cancer diagnosis — and missing the band’s induction to the Rock & Roll Hall of Fame because of it — to Barry Corbin’s oral cancer fears, here’s what’s happening in the oncology space this week.

A phase 2 clinical trial will evaluate iadademstat for patients with relapsed or refractory high-grade neuroendocrine carcinoma.

The Food and Drug Administration approved Libtayo plus chemotherapy for certain patients with non-small cell lung cancer.

After undergoing a colorectal cancer surgery and getting an ostomy, patients may experience a prolapse, but it is not cause to panic, an expert says.

Members of the FDA’s Oncologic Drug Advisory Committee voted that there was insufficient evidence claiming that omburtamab improved survival in patients with neuroblastoma with central nervous system/leptomeningeal metastases.

With advancements making a “huge difference” in lung cancer outcomes, one surgical oncologist said that offering his patients hope is the best part of his job.

Cosela reduced the occurrence of Trodelvy-related side effects in patients with triple-negative breast cancer, according to recent research.

A novel drug, MRT-2359, will be studied in a phase 1/2 trial for patients with MYC-driven cancers.

From a childhood cancer survivor throwing out the first pitch at Game 4 of the World Series to former WWE champion and actor Dwayne “The Rock” Johnson recording a message for a child with brain cancer, here’s what’s happening in the cancer space this week.

Patients with breast cancer can enroll on a clinical trial analyzing elinzanetant for endocrine therapy-related hot flashes.

Talking about the end of life can be difficult, but these conversations are crucial for patients with incurable cancer to have with their clinicians, experts say.

A clinical trial will determine if chemotherapy plus 5-fraction MRIdian SMART will improve survival over chemotherapy alone in patients with locally advanced pancreatic cancer.

Recent research unveiled groups of patients with colorectal cancer who should undergo more frequent scans to detect disease that has spread to the lungs.

The Food and Drug Administration will fast track the development and review of ITM-11 for the treatment of gastroenteropancreatic neuroendocrine tumors.

From the death of “Schitt’s Creek” Emmy winning-producer “Ben Feigin” to “Good Charlotte” signer Joel Madden donating nearly $200,000 to an osteosarcoma nonprofit, here’s what’s happening in the cancer space this week.

Patients with orbital indolent B-cell lymphoma, a rare type of blood cancer, may be able to have fewer side effects and less cancer treatment costs by undergoing a lower dose of radiation that still has similar responses to the standard.

Mepitel Film skin dressings reduced rates of radiation dermatitis — a type of skin-related side effect — compared to standard of care in women undergoing radiation for breast cancer, according to recent research.

The FDA’s approval of Tecvayli was based on findings showing that 61.8% of patients with pretreated, relapsed/refractory myeloma responded to the drug.

An expert recommends that cancer survivors and patients take several actionable steps to improve their quality of sleep.

From Blink-182’s bassist Mark Hoppus discussing his cancer experience in an upcoming book to Bruce Sutter, a Hall-of-Fame pitcher and Cy Young winner, dying of the disease, here’s what’s happening in the cancer space this week.

A clinical trial recently kicked off to study the effects of combining the novel drug BBP-398 plus Lumakras in patients with lung cancer that harbors a KRAS G12 mutation.

An expert offers insight into the major treatment improvements over the past 20 years for early-stage and late-stage lung cancer.

Watch Dr. Aaron S. Mansfield, from Mayo Clinic, discuss the management of mesothelioma during the CURE Educated Patient Lung Cancer Summit.

Watch Dr. David Gerber, from UT Southwestern Medical Center, discuss antibody drug conjugates during the CURE Educated Patient Lung Cancer Summit.

Patients with lung cancer must be educated about their disease in their native language to become better advocates for themselves, an expert explained.

From Kevin Durant’s sneaker that is raising money for cancer to Khloe Kardashian’s urging people to check for moles and melanoma, here’s what’s happening in the cancer space this week.